Category: Featured Content
-
Aequus Pharma (AQS.V) update including Q1,2021 financial highlights
On May 31, 2021 Aequus Pharmaceuticals (AQS.V) reported financial results for Q1, 2021. Aequus is a $19 million pharmaceutical company focused on developing and commercializing high quality, differentiated products. AQS is building a Canadian commercial platform through its own development pipeline and through license-acquisition. On November 20, 2020 Equity Guru’s Chris Parry spoke with Aequus’…
-
Rockridge Resources (ROCK.V) offers re-rating potential, district-scale (VMS) exploration upside – Knife Lake assays are pending
The metals we follow most closely here at Equity Guru—Gold and Copper—have been putting on quite a show of late. Gold, after printing a weekly close above its 200 SMA and slicing through a downtrend line that has held prices in check for months, launched an assault on the $1900 level. Gold boasts a busy…
-
Valeo’s (VPH.C) Novartis (NVS) Deal Impresses Paradigm Capital Analysts
Anyone else watching charts trend downwards? Yeah. There’s a reason that junior market traders hold tight to the saying of “May: sell and go away”, but ‘May’ started unusually early this year. The biggest catalyst of course being the social upheaval that comes with different economies being at different stages of vaccination – and therefore…
-
Gold Mountain’s (GMTN.V) updated PEA targets 19,000/ounce/year production, ramping to 65,000 ounces/year in year-4
On May 27, 2021 Gold Mountain Mining (GMTN.V) announced an updated Preliminary Economic Analysis (PEA) of the Elk Gold Project, located 57 kilometers from Merritt in South Central British Columbia. “If you are looking for exposure to the precious metal and can appreciate the risk/reward dynamics of the junior exploration arena, Gold Mountain is a…
-
Plurilock Security (PLUR.V) provides advanced cybersecurity options for a digital age
Twenty years ago, most North American hackers you met were kids trying to impress their friends. Their older brothers had watched War Games and Hackers and were totally let down when they learned that you couldn’t exactly hack into government installations using a 56K baud modem, no matter how good your script was, but 2001…
-
Element Nutrition (ELMT.C) now public with 15,000-store plant-based plan and strong volume
Plant based food companies are hot, but most have a gigantic Achilles heel in their business model. Here’s how they go: There is no #5, or at least there hasn’t been yet for 90% of plant-based deals. Why? Because shelf space isn’t just hard to get, it’s EXPENSIVE to get. Grocery stores aren’t democracy, they…
-
Cybin (CYBN.E) new tryptamine patent improves outcome quality
Cybin (CYBN.E) filed a new provisional patent application for its ongoing drug candidate programs today, according to a press release. The application includes compositions which the company anticipates will improve pharmacokinetic profiles while keeping efficacy measures of the original molecules. The company’s patent also offers new delivery systems to increase onset of Cybin’s psychedelic tryptamine,…
-
Mind Cure (MCUR.C) has pivoted a few times, but may finally be onto something with its focus on tech
Multiple pivots Mind Cure (MCUR.C) began as a mushroom nootropic deal that has since shifted to ibogaine production and the development digital platforms. The company has been able to raise a considerable amount of cash while having its hands in several different buckets, bringing in $23 million CAD on a bought deal back in February. Mind…